Omnix Medical Launches New Horizon Europe PEPTAMR Infectious Disease Consortium

Autoshop Answers proudly announces Industry Veteran George Zeeks as Vice President of Growth & Development

TolerogenixX Has Received EMA Orphan Drug Designation for MIC-Lx, Strengthening its Regulatory Pathway in Kidney Transplantation

Lighthouse Pharmaceuticals Reports New Evidence that Gingipain Inhibition Benefits Neuropsychiatric Symptoms and Reduces Caregiver Distress...

Invitation — 2026 Half-Year Results Conference for Analysts and Investors

Eisai Presents Latest Findings Showed Etalanetug Reduced Alzheimer's Disease Tau Tangle-Specific Plasma Biomarker MTBR-tau243 at Alzheimer's...

Bottomline CFO Suite Unlocks Stablecoins for Corporate Finance

PANIM Emerges from Stealth to Build Distributed Infrastructure for the Next Generation of Artificial Intelligence

Niu Technologies to Report Second Quarter 2026 Financial Results on August 10, 2026

PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit with the Schall Law Firm

GTM Investors Have Opportunity to Lead ZoomInfo Technologies Inc. Securities Fraud Lawsuit with the Schall Law Firm

GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Nammos Hotels & Resorts and Smokva Bay Partner to Create a Landmark Mediterranean Lifestyle Destination in Montenegro

Nammos Hotels & Resorts and Smokva Bay Partner to Create a Landmark Mediterranean Lifestyle Destination in Montenegro

FUTU Investors Have Opportunity to Lead Futu Holdings Limited Securities Fraud Lawsuit with the Schall Law Firm

HUBG Investors Have Opportunity to Lead Hub Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm

WeRide Accelerates Global Expansion of Its End-to-End Intelligent Driving Solution

GNS Investors Have Opportunity to Lead Genius Group Limited Securities Fraud Lawsuit with the Schall Law Firm

ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Lumina Datamatics Recognized as One of the Most Preferred Workplaces 2026–27 for the 2nd Consecutive Year by Marksmen Daily